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Curcumin has been reported for its anticancer activity, but clinically it suffers from low bioavailability. In this context, 
we explored the potential of a natural bioavailability enhancing agent piperine in the present study. Piperine too has 
anticancer activity, and thereby combination of these two natural ingredients were tested for better therapeutic use. 
Curcumin (50 mg/kg, 100 mg/kg), piperine (10 mg/kg) alone and in combination was evaluated in Dalton lymphoma ascites 
(DLA) bearing mice by assessing various biochemical and histopathological parameters. Treatment with the curcumin at 
two different concentrations and piperine alone has shown some therapeutic benefit in reducing the tumors and increased the 
lifespan of the tested animals (%ILS). The treatment groups have shown significant therapeutic benefits in restoration of 
hematological and biochemical parameters, particularly in combination treatment groups. Precisely, curcumin and piperine 
in combination have shown more significant influence in the restoration of various hematological and biochemical 
parameters. Histopathological observations also revealed that combination of curcumin and piperine improves repairing of 
the tissue damage due to inoculation of lymphoma significantly.  
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Cancer is one of the major non-communicable 
diseases affecting 18.1 million patients worldwide1. It 
is reported to be the second most lethal disease in the 
United States despite 29% drop in the mortality rate 
from 1991 to 20172. The Federal Government has 
spent $147.3 billion on cancer care in 2017, and it is 
estimated to increase in view of the expected rise in 
new cases to 23.6 million by 20303.  In the 
Age‐Standardized Rate (ASR) of cancer incidence 
and mortality globally (24 world areas) for all cancers 
combined, India ranks 18th in cancer incidence with 
ASR 279.8 and the least (24th) in mortality with ASR 
1231. The present study focuses on lymphoma cancer, 
a heterogeneous group of malignant disease with a 
wide spectrum of illnesses, comprising 70 different 
subtypes, and observed most commonly in children, 
next only to Leukemia4,5. Currently, the Non-
Hodgkins lymphoma (NHL), with the new cases of 
509590 in 2018, ranks 13th in cancer incidence1. The 
estimated rate of incidence of NHL in 2012 for India 
was 22 and mortality 1.5 per million population 2.2, 
and mortality 0.15 per 0.1 million population6. Asia is 
reported to lead both in cancer incidence (57.3%) as 
well as in cancer mortality (48.4%)1.  
Though we have different strategies for the 
treatment of cancer viz., radiotherapy, endocrine 
therapy, immunotherapy and chemotherapy, most of 
them are associated complications such as bone 
marrow depression, organ toxicity, alopecia and drug-
induced cancers7. Though the chemotherapy has shown 
promising results irrespective of the stages of cancer, it 
has limitations like non-selectivity and multidrug 
resistance8. The above challenges have encouraged 
researchers to develop innovative methods to resolve 
the issues and also screen natural sources for possible 
potential alternative medicines to treat cancer 
effectively with ‘nil or low’ side effects9-11.  
Curcumin is one of the natural polyphenolic 
compounds obtained from Curcuma longa L. and it 
has been well known as a dye, flavouring and a 
medicinal agent for thousands of years. Traditionally, 
it is used for its antioxidant, anti-inflammatory, 
antiobesity, antiseptic, antitumor, antiplatelet, hepato- 
and immuno-protetive, and chemopreventive 
activities12-16. It has been shown that curcumin and its 
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derivatives increased the cell death in a wide variety 
of cancers like brain tumors17, breast cancer18, ovarian 
cancer19, testicular cancer20 and lymphoma21. 
However, curcumin suffers from low bioavailability, 
and hence require bioavailability enhancing agents for 
optimal result. Piperine, a known anticancer natural 
alkaloid from Piper nigrum (Black Pepper) and  
P. longum (Long Pepper), has been reported to 
enhance curcumin  potential when used in 
combination22,24. In the present study, we observed the 
anticancer activity of curcumin alone and in 
combination with piperine on DAL (Dalton Ascites 
Lymphoma) lymphoma-bearing mice.  
 
Materials and Methods 
 
Collection and authentication of plant material 
Piper nigrum L. fruits were collected from  
the fields of Bengaluru, authenticated by  
Dr. P. Satyanarayana Raju, plant taxonomist, 
Department of Botany and Microbiology, Acharya 
Nagarjuna University, Guntur. 
 
Extraction of piperine 
The dried seed was powdered with the miller, and 
the powder was extracted with ethanol (95%) by 
using a Soxhlet apparatus for 3 h. The solution was 
concentrated at 65°C, andadded with 10% alcoholic 
potassium hydroxide with constant stirring, and was 
filtered. The filtrate was kept aside for overnight and 
the crystals of piperine were separated from the 
flask24. The sample was characterized in FT-IR as 
described in Saha et al.25. 
 
Chemicals 
Curcumin was obtained from Laila Nutraceuticals, 
Vijayawada; 5-fluoro uracil and Trypan Blue were 
obtained from Sigma Chemicals Ltd., India. All the 
other chemicals were obtained from Himedia and SD 
Fine Chemical, Mumbai, India.  
 
Animals and treatment 
Swiss albino mice 20-25 g were procured from 
Biogen, Bangalore, and they were maintained in the 
animal house of Acharya Nagarjuna University 
College of Pharmaceutical Sciences. All the animals 
were provided with standard pellet rat chow and water 
ad libitum and they were maintained at 12 h dark-light 
cycle under room temperatures (22°C±2). The 
experimental protocol was approved by the 
Institutional Animal Ethicks Committee (IAEC) of 
Acharya Nagarjuna University College of Pharmacy. 
DAL cell lines were obtained from the Amala Cancer 
Research Institute, Thrissur. They were injected into 
female mice with 1×106 cells in 0.1 mL for mice and 
the cell lines were maintained by serial intraperitoneal 
(i.p.) transplantations into female mice.  
 
Transplantation of tumor cell lines 
For transplantation of tumor cells, they were 
aspirated into a syringe aseptically and then washed 
with phosphate buffer solution (PBS) twice. The 
washed cells were diluted as 1×106 cells in 0.1 mL of 
PBS and they were transplanted into another animal26. 
 
Selection of test doses 
Test doses of curcumin27 with two different 
concentrations and a single dose of piperine28 were 
selected from the previous literature as 50, 100 and  
10 mg/kg, respectively. 
 
Experimental design for DLA cell line 
In this study, we used 96 female Swiss albino 
mice and they were maintained under laboratory 
condition for 1 week for acclimatization. All the 
animals were divided into 8 groups, each comprising 
12 animals. On the first day of study protocol except 
for Gr. I, all the groups of animals were aseptically 
transplanted with DLA cells from the DLA  
bearing mice through i.p. The standard treatment  
5-fluorouracil (5-FU) was given through i.p. route. 
Curcumin and piperine were administered through 
per os (p.o) route. The protocol was as follows: 
Group I, saline @5 mL/kg, p.o.;Group II, only 
vehicle @5 mL/kg, p.o.; Group III, 5-fluorouracil  
(5-FU) @20 mg/kg i.p. as standard drug; Groups IV 
& V, curcumin @50 and 100 mg/kg, p.o., 
respectively; Group VI, piperine @10 mg/kg, p.o.; 
and Groups VII & VIII piperine @ 10 mg/kg, p.o. 
with curcumin @ 50 and 10 mg/kg, p.o., respectively.  
Except for groups I-III, the rest were treated with 
test doses one week prior to DLA transplantation and 
continued for next 14 days. The test doses were 
suspended and the suspension was given orally. For 
Gr. I-III, the treatment had started on the first day of 
tumor transplantation and continued for 14 days of the 
protocol. On the last day, 6 animals from each group 
were anesthetized with diethyl ether to collect the 
blood samples for estimation of hematological and 
serum biochemical parameters. Peritoneal tumor fluid 
was collected with 18 gauze syringes for the 
determination of tumor volume, packed cell volume 
and viable cell count. They were sacrificed to collect 
the liver samples for in vivo antioxidant studies. The 
remaining animals from each group were observed for 
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mean survival time (MST) and percentage increase in 
life span (%ILS) for 50 days29.  
 
Tumor cell count 
The Viable cell count was observed with the trypan 
blue assay. In this assay, we have used a 0.4% trypan 
blue working solution and this solution was added to 
the cell suspension, kept it aside for 3 min for 
staining. The cells, which attain blue stain were non-
viable and those cells without stain were viable cells. 
Then viable cell count was performed in the 
hemocytometer30.  
 
Tumor volume 
The entire ascetic fluid was collected with the help 
of 18 gauge syringe into a centrifuge tube and 
measured the volume of ascitic fluid from each 
animal29. 
 
Animal weights 
All the animals were weighed before and after the 
withdrawal of ascetic fluid on the 15th day to measure 
the tumor weight29. 
 
Hematological parameters 
The collected blood was used for estimation of 
different hematological parameters like red blood cell 
(RBC) count, white blood cell (WBC) count, 
hemoglobin (Hb) using laboratory procedures29.  
 
Mean survival time and percentage increase in life span 
The remaining 6 animals from each group were 
observed for 50 days for their mean survival time in 
order to calculate the percentage increase in life 
span29. 
 
Serum biochemical parameters 
The serum collected from the animals earlier was 
used for estimation of alanine transaminase (ALT), 
aspartate transaminase (AST), and alkaline 
phosphatase (ALP) with the help of Span Diagnostic 
kits using Semi autoanalyzer.  
 
In vivo antioxidant studies 
 
 
Homogenization of liver tissue 
Liver samples from the animals were washed with 
PBS and then minced into small pieces. Then 1.0 g of 
tissue sample was homogenized in ice-cold 10% 
trichloroacetic acid solution. 
 
Lipid peroxidation 
Lipid peroxidation was performed for the tissue 
homogenate by Ohkawa H method. To 1.0 mL of the 
tissue homogenate we have added 2 mL of TCA-
TBA-HCL reagent (15% w/v trichloroacetic acid; 
0.375% w/v thiobarbituric acid; 0.25 N hydrochloric 
acid). The solution was mixed thoroughly and then 
kept for heating in a boiling water bath for 15 min. 
After cooling the homogenate was centrifuged to get 
supernatant and the absorbance of the supernatant was 
measured at 535 nm31.  
 
Glutathione estimation: 
The reduced glutathione (GSH) estimation was 
performed for the tissue homogenate by minor 
modification in the Ellman method. The homogenate 
was centrifuged in cold centrifuge at 3000 rpm for  
15 min and the 0.5 mL of supernatant was collected. 
The supernatant was added to 2 mL of 0.3 M 
disodium hydrogen phosphate solution, to that 0.2 mL 
of DTNB (dithiobisnitrobenzoate, 0.4 mg/mL of 
sodium citrate) was added. The absorbance was 
measured at 412 nm32. 
 
Histopathology 
Liver samples from each group were used for 
histopathological studies. They were kept in 10% 
formalin solution and were washed and dried in 
different solvents. The samples were embedded in 
paraffin blocks and they were sectioned into 5µ sizes 
which were used for staining with Eosin and 
Haematoxylin33.  
 
Statistical analysis 
Data was projected as Mean±SD. To analyze the 
data we did One-way ANOVA method followed by 
Tukey’s comparison and the P <0.05 was considered 
as a significant result. 
 
Results 
 
FT-IR analysis of piperine 
The extracted piperine was analyzed by the FT-IR 
spectral analysis. The results are shown in Fig. 1 which 
indicates peaks at 2936 cm-1 2849 cm-1 1631 cm-1 
1609 cm-1 1578, 1488 cm-1 1247, 1106 cm-1 
corresponding to C-H (Ar), C-H, C=O, C=C (Diene), 
C=C (Phenyl Ring), and C-O-C, respectively. 
 
Effect on animal weights, tumor volume, and viable tumor cell 
count 
A significant (P ˂0.001) increase in animal body 
wt. was observed in tumor control mice when 
compared with normal control animals. The 5-FU 
treatment group has shown significant (P ˂0.001) 
results in decreasing the body wt. In the treatment 
groups with curcumin 50 and 100 mg/kg was found to be 
a significant reduction in body wt. (P ˂0.05, P ˂0.01), 
respectively. The piperine alone treated group also 
has shown significant (P˂0.05) reduction in body wt. 
The combination groups of curcumin 50 and  
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100 mg/kg with piperine 10 mg/kg (VII & VIII) were 
found to be more significant (P ˂0.001) than the 
individual treatment groups. 
The 5-FU treatment group showed decreased tumor 
volume significantly (P ˂0.001) when compared with 
the tumor control group. Gr. IV (curcumin, 50 mg/kg) 
didn’t show any significant decrease in tumor volume, 
while Gr. V (100 mg/kg) showed a significant 
decrease in tumor volume (P ˂0.05) compared to the 
tumor control. Piperine 10 mg/kg alone (Gr. VI) also 
showed significant (P ˂0.05) decrease in tumor 
volume. The combination groups (Gr. VII & VIII) too 
had more significant (P <0.001) decrease in tumor 
volume than individual groups. 
The 5-FU treated group was shown significant  
(P <0.001) decrease in viable cell count when 
compared with the tumor control group. The 
curcumin 50 mg/kg group (Gr. IV) didn’t show any 
significant difference in viable cell count with the 
tumor control group, whereas Gr. V (curcumin  
100 mg/kg) exhibited significant (P <0.01) decrease 
in tumor cell count compared to the tumor control. Gr. 
VI (piperine 10 mg/kg) also showed significant  
(P <0.05) decrease in tumor cell count. Groups VII & 
VIII (combinations of curcumin 50 and 100 mg/kg 
with piperine 10 mg/kg) have also shown more 
significant (P<0.001) decrease in viable tumor cell 
count compared to the tumor control.  
The effect of curcumin, piperine alone and in 
combination on animal weights, tumor volume and 
viable cell count are summarized in Table 1. 
 
Effect on percentage increase in life span (% ILS) and 
hematological parameters 
The MST was found decreased to 20.5 days in the 
tumor control group while the treatment groups IV & 
V with curcumin 50 and 100 mg/kg and Gr. VI 
(piperine 10 mg) alone showed improved MST 
(%ILS) 22.5 (9.7), 26 (26.8) and 22 (7.3) days, 
 
 
 
Fig. 1 — FT-IR analysis of piperine. [Peaks at 2936 cm-1 2849 cm-1 1631 cm-1 1609 cm-1 1578, 1488 cm-1 1247, 1106 cm-1 corresponding 
to C-H (Ar), C-H, C=O, C=C (Diene), C=C (Phenyl Ring), and C-O-C, respectively]  
  
Table 1 — Effect on animal weights, tumor volume and viable 
tumor cell count 
Groups Animal weights  (g) 
Tumor volume  
(mL) 
Tumor cell 
count 
 I 2.85±0.63 - - 
 II 10.67±0.39*** 8.28±0.63 3.602±0.50 
 III 4.30±0.64*** 2.50±0.46*** 1.358±0.36*** 
 IV 8.99±0.31* 6.83±0.73ns 3.183±0.48ns 
 V 8.65±0.39** 6.52±0.92* 2.757±0.33** 
 VI 8.91±0.37* 6.76±0.99* 2.920±0.14* 
 VII 6.60±0.80*** 5.90±0.68*** 2.063±0.26*** 
 VIII 5.10±0.64*** 4.03±0.99*** 1.735±0.19*** 
[Results are expressed as Mean ± SD; n=6 in each group; 
***significantly different at P <0.001, ** significantly different 
at P <0.01, * significantly different at P <0.05, ns not significant] 
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respectively. The combined groups VII & VIII 
(curcumin 50 and 100 mg/kg and piperine 10 mg/kg) 
showed improved MST (%ILS) 27.5 (34.1) and 34.5 
(68.2) days, respectively. The standard 5-FU 
treatment group had highly improved MST (%ILS) up 
to 37.5 (78.0) days. 
The tumor control group showed a significant  
(P <0.001) decrease in hematological parameters like 
RBC, HG and significant (P <0.001) increase in WBC 
count in comparison with the normal control group. 
The other treatment groups curcumin 50 mg/kg didn’t 
show any significant improvement in RBC count and 
HG amounts, though there was significant (P <0.05) 
decrease in the WBC count. Curcumin 100 mg/kg 
(Gr. V) was found to have significant (P <0.05,  
P <0.05 and P <0.01) influence in increasing RBC 
count, HG amount and decreasing WBC count, 
respectively. Curcumin 50 mg/kg in combination with 
piperine 10 mg/kg (Gr. VII) showed significant  
(P <0.01, P <0.01 and P <0.001) influence in 
improving the RBC, HG and in decreasing WBC 
count, respectively. Gr. VII (curcumin 100 mg/kg in 
combination with piperine 10 mg/kg) also showed 
more significantly improved amount of RBC & HG 
(P <0.001) but decreased WBC count. The standard 
5-FU group (Gr. III) showed significant (P <0.001) 
increase in RBC count, HG levels, and significant 
decrease (P <0.001) in the WBC count.  
The effect of curcumin, piperine alone and in 
combination on % ILS and hematological parameters 
are summarized in Table 2. 
 
Effect on serum biochemical parameters 
The tumor control group was found to have 
significant (P <0.001) elevated levels of ALT, AST 
and ALP. In the curcumin 50 mg/kg treatment group 
(Gr. IV), we observed significant (P<0.01, P<0.01 
and P<0.05) reduction in ALT, AST and ALP, 
respectively. Similarly, Gr. V (curcumin 100 mg/kg) 
too, exhibited significant (P <0.001) reduction in 
ALT, AST and ALP levels in serum. The piperine  
10 mg/kg (Gr. VI) had also shown significantly  
(P <0.01, P< 0.05 and P <0.05) decreased levels of 
ALT, AST and ALP, respectively. Groups VII & VIII 
(curcumin 50 and 100 mg/kg in combination with 
piperine 10 mg/kg and Standard 5-FU (Gr. III) 
showed more significantly (P <0.001) decreased 
levels of ALT, AST and ALP compared to the tumor 
control. The results on serum biochemical parameters 
are shown in Fig. 2. 
 
Effect on in vivo antioxidant studies 
The tumor control group (Gr. III) was found to 
have significant (P <0.001) increase in 
malondialdehyde (MDA) levels compared to the 
normal control. Curcumin 50 mg/kg alsone (Gr. IV) 
didn’t show any significant lowering effect on MDA 
levels whereas, Gr. V (curcumin 100 mg/kg) showed 
significant (P <0.05) lowering effect on MDA levels. 
Piperine 10 mg/kg alone (Gr. VI) also showed any 
significance in lowering of MDA levels, but in 
combination with curcumin 50 and 100 mg/kg (Gr. VII 
& VIII) have shown significant (P <0.01, P <0.001) 
lowering effect on MDA levels, respectively. The 
standard 5-FU treated group showed significant  
 
 
 
Fig. 2 — Effect on serum biochemical parameters. [Results are expressed as Mean ± SD; n=6 in each group; ‘a’ ‘b’ ‘c’ significantly 
different at P <0.001, P <0.01 and P<0.05, respectively] 
 
Table 2 — Effects on percentage increase in life span (% ILS) 
and hematological parameters 
Groups MST % 
ILS 
RBC 
(Million 
cells/mm3) 
WBC 
(Cells/mm3  
× 103) 
HG 
(g/dL) 
I >>50 - 5.47±0.69 5.72±0.71 12.80±1.01 
II 20.5 - 2.22±0.38*** 15.74±1.06*** 5.92±1.01*** 
III 37.5 78.0 4.07±0.30*** 7.48±0.79*** 10.80±0.93*** 
IV 22.5 9.7 2.31±0.39ns 14.07±0.87* 6.73±1.33ns 
V 26 26.8 3.23±0.20* 13.54±1.03** 7.98±1.50* 
VI 22 7.3 2.38±0.40ns 14.07±0.92* 6.89±0.35ns 
VII 27.5 34.1 3.35±0.60** 9.21±0.73*** 8.34±1.24** 
VIII 34.5 68.2 3.94±0.69*** 7.89±0.68*** 10.34±0.61*** 
[Results are expressed as Mean ± SD; n=6 in each group; 
***significantly different at P <0.001, ** significantly different at 
P <0.01, * significantly different at P <0.05, ns not significant] 
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(P <0.001) lowering effect on MDA levels in 
comparison with the normal control. 
The tumor control (Gr. III) was found to have 
significant (P <0.001) depleted levels of GSH 
compared to the normal control (Gr. I). Curcumin 50 
and 100 mg/kg (Gr. IV & V) were found to have 
significantly (P <0.05) increased levels of GSH. 
Piperine 10 mg/kg (Gr. VI) didn’t show any 
significant increase in GSH levels, but in combination 
with curcumin 50 and 100 mg/kg (Gr. VII & VIII) 
have shown significant (P<0.01, P <0.001) increase in 
GSH levels compared to the normal control. The 
standard 5-FU treated (Gr. III) showed significant  
(P <0.001) increase in GSH levels compared to the 
normal control. The results on in vivo antioxidant 
studies are depicted in Fig. 3. 
 
Histopathological study 
In the histopathological study, we observed normal 
lobular morphology of the liver without any steatosis, 
inflammation and infiltration of cells, whereas in the 
tumor control group steatosis with inflammation and 
infiltration of cells was obvious. In the curcumin 50 
mg/kg (Gr. IV). there was not much difference with 
tumor control group. However, Gr. V with100 mg/kg 
curcumin had improved liver morphological structure 
with comparatively less inflammation. Piperine 10 
mg/kg (Gr. VI) didn’t show much difference with the 
tumor control, whereas combination groups (VII & 
VIIII) 50 and 100 mg/kg curcumin, along with 
piperine 10 mg/kg have shown normal morphological 
structure of liver without any steatosis, infiltration of 
cells and with mild inflammation. The standard 5-FU 
treatment group was found to have normal 
morphology without any steatosis, infiltration of cells 
and with mild inflammation. The histopathological 
images are shown in Fig. 4. 
Discussion 
Chemotherapy in cancer treatment often suffers 
from the issue of resistance towards the cancerous 
cells and toxicity towards normal cells. Such issues 
 
 
 
Fig. 3 — Effect on in-vivo anti-oxidant studies. [Results are expressed as Mean ± SD; n=6 in each group; ‘a’ ‘b’ ‘c’ significantly different 
at P <0.001, P <0.01 and P<0.05, respectively. ‘ns’ not significant] 
 
 
 
 
Fig. 4 — Histological alterations in the liver (400X), stained with
H&E. [Arrows represents the infiltration of cells]  
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have encouraged researchers to look for an alternative 
medicine, particularly from natural sources, that  
are considered to be safe. In the present study, 
curcumin has been observed for its anticancer activity 
alone and in combination with piperine. Curcumin  
has been reported for many pharmacological actions 
like Analgesic, antioxidant, anti-inflammatory, 
anticancer, anticonvulsant, antiasthmatic, antifungal, 
antimicrobial, antinociceptive, antiarthritic, antiobesity 
activities11,13,16,34,35; amelioration of hepato- and 
immunotoxicity15 and also used for cardiovascular36, 
metabolic disorders37. Despite having many potential 
health benefits, the clinical application of curcumin is 
limited due to its low water solubility and poor 
bioavailability38. Here, we tried tried with a natural 
bioavailability enhancing agent like piperine to 
improve the bioavailability and its pharmacological 
action of curcumin as shown in earlier similar 
works22,39. 
Piperine is a natural compound obtained from 
black pepper which has been used as a natural 
bioavailability enhancer; this action has been 
attributed by its inhibitory effect on hepatic and 
intestinal glucuronidation of curcumin40. Hence, in the 
present study, we hypothesized that curcumin in the 
presence of piperine would improve its anticancer 
potential on DLA lymphoma-bearing mice. Piperine 
itself has been proved for many pharmacological 
actions like anti-inflammatory, antinociceptive, 
antiarthritic, antidepressant, antioxidant and 
anticancer activities41.  
In the present study, we observed a significant 
increase in the ascites fluid, in tumor control mice 
(Gr. II) compared to the normal control group, ascites 
fluid is the nutritional source for the growth of cancer 
cells. Along with the DLA cancer cells, ascites fluid 
also increased in amount, thereby increasing the body 
wt. of the animals. It is a proper indicator for cancer 
progress42. In the treatment groups, the 5-FU treated 
group (Gr. III) was found to have significant influence 
in decreasing DLA cell viability, tumor volume and 
also the body wt. of the animals. The treatment with 
curcumin decreased the ascites fluid volume along 
with the decreased viability of DAL cancer cells. 
Therefore, the weights of the DLA induced animals 
were reduced, which demonstrates the anti-
proliferative effect of curcumin. Piperine 10 mg/kg 
alone (Gr. VI) had shown significant decrease in DLA 
cell viability, tumor volume and body wt. of the 
animals. Studies have shown that the antitumor 
activity of piperine in DLA induced solid tumors and 
EAC induced ascites tumors in animal models43. The 
present results are in alignment with the previous 
report. The combination of curcumin and piperine 
was found to have a more significant influence in 
decreasing in DLA cell viability, tumor volume and 
the animal weights than alone treated groups.  
Another reliable criterion for anticancer activity is 
prolongation of the lifespan of the animals. The 
curcumin and pipeline alone treated groups were 
found to have %ILS comparable to that of the 
combination groups (Gr. VII & VIII) than the 
individual treatment groups (Gr. IV-VI) which have 
shown equipotency with the standard treatment group. 
Therefore, the %ILS in the combination treatment 
group, could be attributed to its prevention of tumor 
development by the combined action of curcumin and 
piperine.  
The previous scientific reports have shown that the 
myelosuppression and anemia are associated with 
ascites carcinoma41. In the present study, the DLA 
control group of animals showed reduced RBC, 
hemoglobin content and elevated WBC count in the 
animals. The results are in agreement with the 
previous scientific reports44. The anemia observed in 
DLA bearing mice may be attributed to the reduction 
in RBC count or iron deficiency, either by hemolysis 
or myelopathic conditions45. In the present study, the 
combination treatment groups (Gr. VII & VIII) were 
found to have the better therapeutic benefit of 
increasing the RBC, hemoglobin contents and also in 
decreasing WBC count, than the alone treatment 
groups (Gr. IV-VI). Phytochemical compounds are 
known to reduce myelotoxicity due to immune 
boosting and free radical scavenging activity46. The 
curcumin and piperine both have been proven for 
their antioxidant potential and immune boosting 
properties in the animal models13,15,42,47. Thus, the 
present results suggest that combination of curcumin 
and piperine significantly ameliorated the 
hematological alterations induced by DLA 
lymphoma.  
The ALT, AST, and ALP are the biomarkers which 
indicate liver function. The elevation of ALT and 
AST levels are indicative of liver parenchymal cell 
injury and the elevation of ALP is indicative of 
cholestasis or infiltrative liver diseases26. Impaired 
liver function was also observed due to cancer and it 
will be indicated by the elevated levels of ALT, AST 
and ALP in the serum48. In the present study, the 
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tumor control group was found to have a greater 
increase in ALT, AST and ALP levels as in line with 
the previous literature48. Earlier reports have also 
shown that the curcumin and piperin treatment reduce 
the elevated levels of ALT, AST and ALP by 
protecting the liver cells from injury23,49. In agreement 
with the previous studies, the individual treatment 
groups (Gr. IV-VI) were found to have lowered levels 
of ALT, AST and ALP. In the combination group  
(Gr. VII & VIII) a greater decrease was obvious in 
these liver biomarkers, indicating a better therapeutic 
benefit with the combined effect of curcumin and 
piperine. The antioxidant potential of both the agents 
could be attributed for significant decrease in the 
levels of ALT, AST and ALP. 
Tumors itself have the ability to produce more 
amount of oxygen free radicals which act on the lipid 
membranes and cause lipid peroxidation producing 
MAD. The innate antioxidant defensive system 
mitigates the effects of this oxygen-free radicals50. In our 
study, the tumor control was found to have a significant 
increase in MDA levels and decreased levels of GSH 
whereas the treatment groups with curcumin, piperine 
alone have shown little decrease in MDA and slight 
improvement in GSH levels. However,  in curcumin, 
along with piperine treatment groups (Gr. VII & VIII), 
the levels of MDA and GSH were found to be 
normalized compared to the normal control group of 
animals. The histopathological investigations have also 
supported the therapeutic benefit of curcumin and 
piperine combination for the cancer treatment.  
 
Conclusion 
The results of this study suggest that the therapeutic 
benefits of the curcumin (@ 50 and 100 mg/kg, p.o.) in 
the treatment of cancer could be improved effectively 
with the combination of piperine @10 mg/kg, p.o. 
However, further research is required to understand 
the mechanism at the molecular level and also the 
pharmacokinetics of the individual and combination 
treatment groups.  
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